DNA double-strand breaks lead to activation of hypermethylated in cancer 1 (hic1) by sumoylation to regulate DNA repair

Journal of Biological Chemistry

Volumn 288, Issue 15, 2013, Pages 10254-10264

  Dehennaut, Vanessa ^a   Loison, Ingrid ^a   Dubuissez, Marion ^a   Nassour, Joe ^a   Abbadie, Corinne ^a   Leprince, Dominique ^a  

^a UNIV LILLE   (France)

Author keywords

[No Author keywords available]

Indexed keywords

DEACETYLATION; DNA DOUBLE-STRAND BREAKS; ECTOPIC EXPRESSIONS; HUMAN FIBROBLAST; REPRESSOR ACTIVITY; TRANSCRIPTIONAL REPRESSORS; TUMOR SUPPRESSOR GENES; TUMORIGENESIS;

ACTIVATION ANALYSIS; AMINO ACIDS; CELL CULTURE; DISEASES; DNA;

REPAIR;

DOUBLE STRANDED DNA; SUMO PROTEIN; UBIQUITIN PROTEIN LIGASE E3;

ACETYLATION; ANIMAL CELL; ARTICLE; CARCINOGENESIS; CONTROLLED STUDY; DNA DAMAGE; DNA REPAIR; ENZYME ACTIVATION; ENZYME KINETICS; EPIGENETICS; GENE ACTIVATION; GENE EXPRESSION REGULATION; GENE MUTATION; GENE SILENCING; HIC1 GENE; HUMAN; HUMAN CELL; IMMUNOPRECIPITATION; NONHUMAN; POINT MUTATION; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; PROTEIN PROTEIN INTERACTION; SUMOYLATION; TUMOR SUPPRESSOR GENE;

ACETYLATION; ANIMALS; ANTINEOPLASTIC AGENTS, PHYTOGENIC; CELL TRANSFORMATION, NEOPLASTIC; CERCOPITHECUS AETHIOPS; COS CELLS; DNA BREAKS, DOUBLE-STRANDED; DNA REPAIR; ETOPOSIDE; FIBROBLASTS; HISTONE DEACETYLASES; HUMANS; KRUPPEL-LIKE TRANSCRIPTION FACTORS; MI-2 NUCLEOSOME REMODELING AND DEACETYLASE COMPLEX; MUTATION; REPRESSOR PROTEINS; SIRTUIN 1; SUMOYLATION;

EID: 84876230292     PISSN: 00219258     EISSN: 1083351X     Source Type: Journal    
DOI: 10.1074/jbc.M112.421610     Document Type: Article

References (46)

1. Wales, M. M., Biel, M. A., el Deiry, W., Nelkin, B. D., Issa, J. P., Cavenee, W. K., Kuerbitz, S. J., and Baylin, S. B. (1995) p53 activates expression of HIC-1, a new candidate tumour suppressor gene on 17p13.3. Nat. Med. 1, 570-577
2. Fleuriel, C., Touka, M., Boulay, G., Guérardel, C., Rood, B. R., and Leprince, D. (2009) HIC1 (hypermethylated in cancer 1) epigenetic silencing in tumors. Int. J. Biochem. Cell Biol. 41, 26-33
3. Pinte, S., Stankovic-Valentin, N., Deltour, S., Rood, B. R., Guérardel, C., and Leprince, D. (2004) The tumor suppressor gene HIC1 (hypermethylated in cancer 1) is a sequence-specific transcriptional repressor: definition of its consensus binding sequence and analysis of its DNA binding and repressive properties. J. Biol. Chem. 279, 38313-38324
4. Deltour, S., Guerardel, C., and Leprince, D. (1999) Recruitment of SMRT/ N-CoR-mSin3A-HDAC-repressing complexes is not a general mechanism for BTB/POZ transcriptional repressors: the case of HIC-1 and FBP-B. Proc. Natl. Acad. Sci. U.S.A. 96, 14831-14836
5. Deltour, S., Pinte, S., Guerardel, C., Wasylyk, B., and Leprince, D. (2002) The human candidate tumor suppressor gene HIC1 recruits CtBP through a degenerate GLDLSKK motif. Mol. Cell. Biol. 22, 4890-4901
6. Stankovic-Valentin, N., Verger, A., Deltour-Balerdi, S., Quinlan, K. G., Crossley, M., and Leprince, D. (2006) A L225A substitution in the human tumour suppressor HIC1 abolishes its interaction with the corepressor CtBP. FEBS J. 273, 2879-2890
7. Stankovic-Valentin, N., Deltour, S., Seeler, J., Pinte, S., Vergoten, G., Guérardel, C., Dejean, A., and Leprince, D. (2007) An acetylation/deacetylation- SUMOylation switch through a phylogenetically conserved psiKXEP motif in the tumor suppressor HIC1 regulates transcriptional repression activity. Mol. Cell. Biol. 27, 2661-2675
8. Geiss-Friedlander, R., and Melchior, F. (2007) Concepts in sumoylation: a decade on. Nat. Rev. Mol. Cell Biol. 8, 947-956
9. Hay, R. T. (2005) SUMO: a history of modification. Mol. Cell 18, 1-12
10. Gareau, J. R., and Lima, C. D. (2010) The SUMO pathway: emerging mechanisms that shape specificity, conjugation and recognition. Nat. Rev. Mol. Cell Biol. 11, 861-871
11. Zhao, X., Sternsdorf, T., Bolger, T. A., Evans, R. M., and Yao, T. P. (2005) Regulation of MEF2 by histone deacetylase 4- and SIRT1 deacetylasemediated lysine modifications. Mol. Cell. Biol. 25, 8456-8464
12. Grégoire, S., and Yang, X. J. (2005) Association with class IIa histone deacetylases upregulates the sumoylation of MEF2 transcription factors. Mol. Cell. Biol. 25, 2273-2287
13. Van Rechem, C., Boulay, G., Pinte, S., Stankovic-Valentin, N., Guérardel, C., and Leprince, D. (2010) Differential regulation of HIC1 target genes by CtBP and NuRD, via an acetylation/SUMOylation switch, in quiescent versus proliferating cells. Mol. Cell. Biol. 30, 4045-4059
14. Carter, M. G., Johns, M. A., Zeng, X., Zhou, L., Zink, M. C., Mankowski, J. L., Donovan, D. M., and Baylin, S. B. (2000) Mice deficient in the candidate tumor suppressor gene Hic1 exhibit developmental defects of structures affected in the Miller-Dieker syndrome. Hum. Mol. Genet. 9, 413-419
15. Boulay, G., Malaquin, N., Loison, I., Foveau, B., Van Rechem, C., Rood, B. R., Pourtier, A., and Leprince, D. (2012) Loss of hypermethylated in cancer 1 (HIC1) in breast cancer cells contributes to stress-induced migration and invasion through 2-adrenergic receptor (ADRB2) misregulation. J. Biol. Chem. 287, 5379-5389
16. Foveau, B., Boulay, G., Pinte, S., Van Rechem, C., Rood, B. R., and Leprince, D. (2012) The receptor tyrosine kinase EphA2 is a direct target gene of hypermethylated in cancer 1 (HIC1). J. Biol. Chem. 287, 5366-5378
17. Dehennaut, V., and Leprince, D. (2009) Implication of HIC1 (hypermethylated in cancer 1) in the DNA damage response. Bull. Cancer 96, E66-72
18. Dou, H., Huang, C., Van Nguyen, T., Lu, L. S., and Yeh, E. T. (2011) SUMOylation and de-SUMOylation in response to DNA damage. FEBS Lett. 585, 2891-2896
19. Bekker-Jensen, S., and Mailand, N. (2011) The ubiquitin- and SUMO-dependent signaling response toDNAdouble-strand breaks. FEBS Lett. 585, 2914-2919
20. Chen, W. Y., Wang, D. H., Yen, R. C., Luo, J., Gu, W., and Baylin, S. B. (2005) Tumor suppressor HIC1 directly regulates SIRT1 to modulate p53- dependent DNA-damage responses. Cell 123, 437-448
21. Guerardel, C., Deltour, S., Pinte, S., Monte, D., Begue, A., Godwin, A. K., and Leprince, D. (2001) Identification in the human candidate tumor suppressor gene HIC-1 of a new major alternative TATA-less promoter positively regulated by p53. J. Biol. Chem. 276, 3078-3089
22. Britschgi, C., Rizzi, M., Grob, T. J., Tschan, M. P., Hügli, B., Reddy, V. A., Andres, A. C., Torbett, B. E., Tobler, A., and Fey, M. F. (2006) Identification of the p53 family-responsive element in the promoter region of the tumor suppressor gene hypermethylated in cancer 1. Oncogene 25, 2030-2039
23. Boulay, G., Dubuissez, M., Van Rechem, C., Forget, A., Helin, K., Ayrault, O., and Leprince, D. (2012) Hypermethylated in cancer 1 (HIC1) recruits polycomb repressive complex 2 (PRC2) to a subset of its target genes through interaction with human polycomb-like (hPCL) proteins. J. Biol. Chem. 287, 10509-10524
24. Huang, T. T., Wuerzberger-Davis, S. M., Wu, Z. H., and Miyamoto, S. (2003) Sequential modification of NEMO/IKK by SUMO-1 and ubiquitin mediates NF-B activation by genotoxic stress. Cell 115, 565-576
25. Shiloh, Y. (2006) The ATM-mediated DNA-damage response taking shape. Trends Biochem. Sci. 7, 402-410
26. Bekker-Jensen, S., and Mailand, N. (2010) Assembly and function of DNA double-strand break repair foci in mammalian cells. DNA Repair 9, 1219-1228
27. Riches, L. C., Lynch, A. M., and Gooderham, N. J. (2008) Early events in the mammalian response to DNA double-strand breaks. Mutagenesis 23, 331-339
28. Yang, Y., Fu, W., Chen, J., Olashaw, N., Zhang, X., Nicosia, S. V., Bhalla, K., and Bai, W. (2007) SIRT1 sumoylation regulates its deacetylase activity and cellular response to genotoxic stress. Nat. Cell Biol. 9, 1253-1262
29. Gill, G. (2005) Something aboutSUMOinhibits transcription. Curr. Opin. Genet. Dev. 15, 536-541
30. Yang, S. H., Jaffray, E., Hay, R. T., and Sharrocks, A. D. (2003) Dynamic interplay of the SUMO and ERK pathways in regulating Elk-1 transcriptional activity. Mol. Cell 12, 63-74
31. Ross, S., Best, J. L., Zon, L. I., and Gill, G. (2002) SUMO-1 modification represses Sp3 transcriptional activation and modulates its subnuclear localization. Mol. Cell 10, 831-842
32. Park, M. A., Seok, Y. J., Jeong, G., and Lee, J. S. (2008) SUMO1 negatively regulates BRCA1-mediated transcription, via modulation of promoter occupancy. Nucleic Acids Res. 36, 263-283
33. Morris, J. R., Boutell, C., Keppler, M., Densham, R., Weekes, D., Alamshah, A., Butler, L., Galanty, Y., Pangon, L., Kiuchi, T., Ng, T., and Solomon, E. (2009) The SUMO modification pathway is involved in the BRCA1 response to genotoxic stress. Nature 462, 886-890
34. Lee, Y. K., Thomas, S. N., Yang, A. J., and Ann, D. K. (2007) Doxorubicin down-regulates Kruppel-associated box domain-associated protein 1 sumoylation that relieves its transcription repression on p21WAF1/CIP1 in breast cancer MCF-7 cells. J. Biol. Chem. 282, 1595-1606
35. Li, X., Lee, Y. K., Jeng, J. C., Yen, Y., Schultz, D. C., Shih, H. M., and Ann, D. K. (2007) Role for KAP1 serine 824 phosphorylation and sumoylation/ desumoylation switch in regulating KAP1-mediated transcriptional repression. J. Biol. Chem. 282, 36177-36189
36. Mabb, A. M., Wuerzberger-Davis, S. M., and Miyamoto, S. (2006) PIASy mediates NEMO sumoylation and NF-B activation in response to genotoxic stress. Nat. Cell Biol. 8, 986-993
37. Ivanov, A. V., Peng, H., Yurchenko, V., Yap, K. L., Negorev, D. G., Schultz, D. C., Psulkowski, E., Fredericks, W. J., White, D. E., Maul, G. G., Sadofsky, M. J., Zhou, M. M., and Rauscher, F. J., 3rd (2007) PHD domain-mediated E3 ligase activity directs intramolecular sumoylation of an adjacent bromodomain required for gene silencing. Mol. Cell 28, 823-837
38. Nemoto, S., Fergusson, M. M., and Finkel, T. (2004) Nutrient availability regulates SIRT1 through a forkhead-dependent pathway. Science 306, 2105-2108
39. Martin, M., Kettmann, R., and Dequiedt, F. (2007) Class IIa histone deacetylases: regulating the regulators. Oncogene 26, 5450-5467
40. Xu, X., Vatsyayan, J., Gao, C., Bakkenist, C. J., and Hu, J. (2010) HDAC2 promotes eIF4E sumoylation and activates mRNA translation gene specifically. J. Biol. Chem. 285, 18139-18143
41. Gao, C., Ho, C. C., Reineke, E., Lam, M., Cheng, X., Stanya, K. J., Liu, Y., Chakraborty, S., Shih, H. M., and Kao, H. Y. (2008) Histone deacetylase 7 promotes PML sumoylation and is essential for PML nuclear body formation. Mol. Cell. Biol. 28, 5658-5667
42. Yang, Y., Tse, A. K., Li, P., Ma, Q., Xiang, S., Nicosia, S. V., Seto, E., Zhang, X., and Bai, W. (2011) Inhibition of androgen receptor activity by histone deacetylase 4 through receptor SUMOylation. Oncogene 30, 2207-2218
43. Lee, F. Y., Faivre, E. J., Suzawa, M., Lontok, E., Ebert, D., Cai, F., Belsham, D. D., and Ingraham, H. A. (2011) Eliminating SF-1 (NR5A1) sumoylation in vivo results in ectopic hedgehog signaling and disruption of endocrine development. Dev. Cell 21, 315-327
44. Li, D. Q., Pakala, S. B., Reddy, S. D., Ohshiro, K., Peng, S. H., Lian, Y., Fu, S. W., and Kumar, R. (2010) Revelation of p53-independent function of MTA1 in DNA damage response via modulation of the p21 WAF1-proliferating cell nuclear antigen pathway. J. Biol. Chem. 285, 10044-10052
45. Chou, D. M., Adamson, B., Dephoure, N. E., Tan, X., Nottke, A. C., Hurov, K. E., Gygi, S. P., Colaiácovo, M. P., and Elledge, S. J. (2010) A chromatin localization screen reveals poly(ADP ribose)-regulated recruitment of the repressive polycomb and NuRD complexes to sites of DNA damage. Proc. Natl. Acad. Sci. U.S.A. 107, 18475-18480
46. Li, D. Q., Divijendra Natha Reddy, S., Pakala, S. B., Wu, X., Zhang, Y., Rayala, S. K., and Kumar, R. (2009) MTA1 coregulator regulates p53 stability and function. J. Biol. Chem. 284, 34545-34552